Target intelligence / Profile preview

Olfactory receptor 51I2 (OR51I2)

Target
OR51I2
Molecular classification
G protein-coupled receptor, Receptor, Odorant receptor, Class A GPCR (rhodopsin-like)
01

Overview

Olfactory receptor 51I2 (OR51I2) is a transmembrane protein expressed predominantly in the olfactory epithelium, where it interacts with odorant molecules and initiates neuronal signaling for smell perception[5][4]. It belongs to the large family of G protein-coupled receptors (GPCRs), specifically the class A (rhodopsin-like) subgroup[5][3]. The binding pocket of OR51I2 is adapted to recognize carboxylic acid–containing odorants, leveraging a highly conserved arginine residue that interacts closely with the carboxyl group of the ligand, a feature shared within its subfamily[1][2]. The receptor undergoes a distinct structural rearrangement upon agonist (odorant) binding, leading to activation of G protein signaling pathways (notably involving Gαolf and Gαs)[1][2]. While its primary function is olfactory signaling, emerging evidence suggests extranasal expression and possible involvement in physiological processes beyond smell[3]. Its direct therapeutic targeting is currently unexplored, and no drugs selectively modulating OR51I2 have entered clinical use.

Other names
Odorant receptor HOR5'beta12Olfactory receptor OR11-38OR11-38HOR5'Beta12
02

Mechanism of action

Agonist binding (odorant activation triggers G protein signaling and subsequent cAMP production); Selectivity determined by tight, supportive hydrophobic and ionic interactions between the odorant and receptor binding pocket

03

Biological functions

Signal transductionSmell (olfactory perception)Potential extranasal physiological roles (e.g., in brain, pancreas, testes)
04

Disease associations

Cancer (dysregulation implicated, particularly for some family members, e.g., OR51E2)Other (possible roles in extranasal tissues, but specific evidence for OR51I2 not well established)
05

Safety considerations

None known; olfactory receptors are not currently pharmacological targets for approved therapeutics. Safety concerns would be speculative.
06

Interacting drugs

None established for therapeutic purposes; primarily interacts with odorant molecules (e.g., fatty acids/carboxylic acid odorants)
07

Biomarkers

None established for clinical use

Beyond the preview

Go deeper on Olfactory receptor 51I2 (OR51I2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor 51I2 (OR51I2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call